Apr 26, 2021
U.S. will share AstraZeneca vaccines with world
, The Associated Press
Diversification in vaccine suppliers only way to secure millions of doses: Procurement minister
VIDEO SIGN OUT
WASHINGTON - The White House tells The Associated Press that the U.S. will begin sharing its entire stock of COVID-19 vaccines from AstraZeneca once the vaccine clears federal safety reviews.
As many as 60-million doses are expected to be available for export in the coming months.
The move greatly expands on the Biden administration's action last month to share about four-million doses of the vaccine with Mexico and Canada.
The Oxford-AstraZeneca drug is widely in use around the world but not yet authorized by the U.S. Food and Drug Administration.
Related
Politics
BNN Bloomberg Picks
-
4:00Ottawa moves to raise inclusion rate on capital gains taxes in 2024 budget
-
6:31Capital gains changes in budget will raise taxes for many: tax accountant
-
8:19What's the neutral rate, and why did the Bank of Canada raise it?
-
5:56Budget 2024 prioritizes housing while taxing highest earners, deficit projected at $39.8B
-
7:46Portfolio manager says loonie could fall to half of greenback's value
-
4:55Some of the key highlights from the Liberal government's 2024 federal budget